#POLB Poolbeg Pharma PLC – SAB Endorses Influenza Drug Targets October 26, 2023 – Posted in: Blog, Poolbeg Pharma (POLB)

26 October 2023 – (AIM: POLB, OTCQB: POLBF, ‘Poolbeg’ or the ‘Company’), a clinical-stage biopharmaceutical company targeting diseases with a high unmet medical need, announces that its Scientific Advisory Board (‘SAB’) has endorsed the influenza drug targets identified in its AI-led drug discovery programme.   Key highlights   ·      Prioritisation of influenza drug targets which have the highest likelihood of success ·      New potential collaborative routes to maximise the impact of the outputs identified ·      Ongoing discussions with…

Continue reading